Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

131 ARTÍCULOS , VIENDO DEL 16 AL 30

Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease

Counts SE, He B, Prout JG, Michalski B, Farotti L, Fahnestock M, Mufson EJ.

Curr Alzheimer Res. 2016;13(7):800-8. doi: 10.2174/1567205013666160129095649.

Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment

González-Domínguez R, Rupérez FJ, García-Barrera T, Barbas C, Gómez-Ariza JL.

Curr Alzheimer Res. 2016;13(6):641-53. doi: 10.2174/1567205013666160129095138.

Amyloid imaging: Past, present and future perspectives

Villemagne VL.

Ageing Res Rev. 2016 Sep;30:95-106. doi: 10.1016/j.arr.2016.01.005. Epub 2016 Jan 28.

Neuroimaging biomarkers in Alzheimer's disease and other dementias

Villemagne VL, Chételat G.

Ageing Res Rev. 2016 Sep;30:4-16. doi: 10.1016/j.arr.2016.01.004. Epub 2016 Jan 28.

Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives

Wang J, Tan L, Yu JT.

J Alzheimers Dis. 2016;50(4):927-45. doi: 10.3233/JAD-150826.

Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review

Hung AS, Liang Y, Chow TC, Tang HC, Wu SL, Wai MS, Yew DT.

Prog Histochem Cytochem. 2016 May;51(1):1-8. doi: 10.1016/j.proghi.2016.01.001. Epub 2016 Jan 16.

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein

Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group.

J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111.

The clinical picture of Alzheimer's disease in the decade before diagnosis: clinical and biomarker trajectories

Ritchie K, Carrière I, Berr C, Amieva H, Dartigues JF, Ancelin ML, Ritchie CW.

J Clin Psychiatry. 2016 Mar;77(3):e305-11. doi: 10.4088/JCP.15m09989.

The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease

Hays CC, Zlatar ZZ, Wierenga CE.

Cell Mol Neurobiol. 2016 Mar;36(2):167-79. doi: 10.1007/s10571-015-0261-z. Epub 2016 Feb 22.

Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis

Ma J, Zhang W, Wang HF, Wang ZX, Jiang T, Tan MS, Yu JT, Tan L.

Curr Alzheimer Res. 2016;13(3):223-33. doi: 10.2174/156720501303160217111434.

Biomarkers and Cellular Signal Detection for Alzheimer's Disease, Stroke, and Immune System Mediated Disorders

Maiese K.

Curr Neurovasc Res. 2016;13(2):93-5. doi: 10.2174/1567202613999160226165448.

Alzheimer's disease

Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM.

Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.

What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?

Andriuta D, Moullart V, Schraen S, Devendeville A, Meyer ME, Godefroy O; Alzheimer’s Disease Neuroimaging.

J Alzheimers Dis. 2016;51(3):793-800. doi: 10.3233/JAD-150829.

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease

Delnomdedieu M, Duvvuri S, Li DJ, Atassi N, Lu M, Brashear HR, Liu E, Ness S, Kupiec JW.

Alzheimers Res Ther. 2016 Mar 1;8(1):12. doi: 10.1186/s13195-016-0177-y.

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

Suárez-Calvet M, Kleinberger G, Araque Caballero MÁ, Brendel M, Rominger A, Alcolea D, Fortea J, Lleó A, Blesa R, Gispert JD, Sánchez-Valle R, Antonell A, Rami L, Molinuevo JL, Brosseron F, Traschütz A, Heneka MT, Struyfs H, Engelborghs S, Sleegers K, Van Broeckhoven C, Zetterberg H, Nellgård B, Blennow K, Crispin A, Ewers M, Haass C.

EMBO Mol Med. 2016 May 2;8(5):466-76. doi: 10.15252/emmm.201506123. Print 2016 May.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias